Author: Bryan King, MD

DSM 5 and Autism- An Update From the Front Lines Part 2

We’ve all heard the adage: “if it ain’t broke, don’t fix it”. The questions we face surrounding autism in the DSM 5 are first, is it broken, and if so, how should it be fixed? In the current system, Autism, Asperger’s Disorder, and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) are treated like distinct conditions. Indeed, if a medication is FDA approved for the treatment of Autism, that approval does not extend to Asperger’s or PDD. It is not uncommon for service systems to treat these diagnoses as distinct conditions, and differentially recognize them (or not).  Read full post »

DSM 5 and Autism- An Update From the Front Lines

A new round of interest in the potential impact of diagnostic changes being proposed for the Diagnostic and Statistical Manual of Mental Disorders, or “DSM”, was sparked last week by a report suggesting that many individuals would likely lose their diagnoses if the defining criteria for autism, Asperger’s disorder and Pervasive Developmental Disorder Not Otherwise Specified are changed. A number of the stories that we were seeing suggested that the definition was being tightened because of concerns relating to over-diagnosis, with one commenter offering that the change in definition would solve the autism epidemic by “nipping it in the bud”.

As one who has been directly involved in the DSM process and whose fingerprints are on some of these proposed changes, I have been asked to clarify what is going on and thought it might be helpful to share some thoughts here.  Read full post »